TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
Cryogenetics AS
Closing information (x1000 SEK)
| Closing information | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Turnover |
40,360
|
32,960
|
29,201 |
| Financial expenses |
1,060
|
994
|
770 |
| Earnings before taxes |
8,470
|
3,878
|
3,782 |
| Total assets |
51,521
|
46,649
|
37,648 |
| Current assets |
25,930
|
24,726
|
21,796 |
| Current liabilities |
8,636
|
10,187
|
7,474 |
| Equity capital |
31,577
|
25,408
|
20,290 |
| - share capital |
4,371
|
4,681
|
4,541 |
Financial ratios
| Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Solvency |
61.3%
|
54.5%
|
53.9% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
21.0%
|
11.8%
|
13.0% |
| Return on assets (ROA) |
18.5%
|
10.4%
|
12.1% |
| Current ratio |
300.3%
|
242.7%
|
291.6% |
| Return on equity (ROE) |
26.8%
|
15.3%
|
18.6% |
| Change turnover |
9,584
|
2,854
|
5,157 |
| Change turnover % |
31%
|
9%
|
21% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.